Build any personalised health, fitness or wellness application using a simple plug and play approach

Optimise

A powerful, comprehensive cloud-based platform, connecting you to fully personalised data-driven healthcare possibilities.

Using the latest technology and science to analyse broad sets of health data, you’ll be able to achieve better results as well as increase client engagement and retention.

With power at its core, Optimise is the essence of user-friendliness and customisability. Any wellness or healthcare provider can simply, easily and quickly benefit, taking their practice to a whole new level. The hard work is done for you.

More Information

Get in Touch

Optimise

A powerful, comprehensive cloud-based platform, connecting you to fully personalised data-driven healthcare possibilities.

Using the latest technology and science to analyse broad sets of health data, you’ll be able to achieve better results as well as increase client engagement and retention.

With power at its core, Optimise is the essence of user-friendliness and customisability.

Any wellness or healthcare provider can simply, easily and quickly benefit, taking their practice to a whole new level. The hard work is done for you.

More Information

Get in Touch

More Information

A simple 4 step process…

Built with you in mind

The Team

Elliot Sylvester

Chief Executive Officer and Co-Founder

Nikola Stanojevic

Chief Technical Officer and Co-Founder

Dr Shara Cohen

Chief Scientific Officer

Dr Mohamed Zahran

Regional Manager – The Gulf

Valentin Corejl

Systems Developer and Analyst

Nenad Strainovic

Back-end Developer

Milos Jeremic

UI/UX Designer and Front-end Developer

Dr Jelena Dragicevic

General Practitioner and Analyst

See Advisory Board Members

Advisory Board

Dr Charlotte Lawson

Scientific Board Member

Dr Kerry McLaughlin

Scientific Board Member

Dr Sharmila Bakshi

Scientific Board Member

Dr Sharon Brookes

Scientific Board Member

Dr Claire Morgan

Scientific Board Member

Andrew Mark

Scientific Board Member

Niga Nawroly

Scientific Board Member

Ralph Coney

Scientific Board Member

Trevor Fitzpatrick

Scientific Board Member

Contact

We are currently looking for pioneering
health, wellness and fitness partners.

Get in touch.

+44 207 118 2242

enquiries@optimisedhealthcare.co.uk

47 High Street
Barnet, Herts
United Kingdom
EN5 5UW

Elliot Sylvester

Elliot Sylvester spent 17 years at the forefront of Information Technology as founder and managing director of Online Group, a company specialising in the design and integration of complex high-level management systems for large global corporates and banking institutions. In 2007 Sylvester made an unconventional move to follow his long-term passion and transitioned from the corporate environment into life sciences. After 7 years of research in the area of behavioural biology as well as modern medical systems, Sylvester moved on to hold two directorships at specialist clinics in the Harley Street medical district.

In 2015, Sylvester’s efforts and experience culminated with the co-founding of Optimised Healthcare along with its sister company, Augmented Health, a specialist medical consultancy focused on the diagnosis and treatment of complex chronic conditions using a systems medicine approach.

Sylvester’s business leadership and proven ability to deliver and integrate highly complex systems into existing environmental structures, combined with his exposure to the cutting edge of systems medicine, puts him in a unique position to lead this multifaceted project.

Nikola Stanojevic

As Chief Technical Officer and co-founder of Optimised Healthcare, Nikola Stanojevic specialises in predictive, preventive and personalised medicine as well as biomedical analysis.

Stanojevic holds a BSc in Molecular Biology, an MSc in Biomedical Sciences and is a certified Nutritionist and Dietician. As Co-Founder and Lead Consultant of Augmented Health *sister company to Optimised Healthcare), he specialised in the frontline application of personalised medicine systems to treat complex chronic conditions. Prior to this, he has held various freelance consultant positions with several leading pharmaceutical companies.

Stanojevic is passionate about giving clinicians access to the latest technology and empowering them with extensive biomedical data so that they can make informed, evidence-based decisions to optimise their client’s health.

Along with his wife Angelica, a fertility researcher at Optimised Healthcare, Nikola enjoys extreme sports including caving parachuting and SCUBA diving. His passion for sports has gravitated him towards working closely with Personal Trainers and Nutritionists to combine their skillset with his expertise in scientific biomedicine.

Dr Shara Cohen

As Chief Scientific Officer, Dr Shara Cohen oversees the scientific strategy of Optimised healthcare and maintains the quality and integrity of its output.

Dr Cohen received her first degree in Applied Biology in 1985 and a PhD in Immunology in 1989. She has spent time as a research scientist and lecturer at Addenbrooke’s Hospital in Cambridge, the Kennedy Institute of Rheumatology and The Royal Postgraduate Medical School both in London, and The Mount Sinai Hospital in New York.

In 2001, she left mainstream science to establish a Life Science Communications company, Euroscicon Ltd – the first international independent academic life science events company in the world. In 2015, Euroscicon became the first company to produce live-streamed only independent academic life science events and its success lead to its buyout by a global leading conference company.

Dr Cohen has over 100 peer-reviewed scientific publications, has authored several books and has been a commissioning editor. Her stem cell research was pivotal in establishing cord blood transplantation as mainstream procedure and she was a founding scientific member of Eurocord.

Dr Mohamed Zahran

Since obtaining his medical degree in 1988, Dr Zahran has achieved two diplomas in Healthcare Management as well as an MBA in Health Services Management from The University of Plymouth, UK.

After working in clinical practice, Dr Zahran has gained a wealth of experience in healthcare management, with senior roles at Medics UK International Ltd and BUPA Cromwell Hospital.

In 2010 he became the CEO of Alqilaa Ltd before working as a Consultant and Advisor to the Libyan Health Office. More recently he has worked as the Chief Operating Officer for Birtely Pharma UAE.

As General Regional Manager for the Gulf Region at Optimised Healthcare, Dr Zahran relies on his business acumen and healthcare experience to develop opportunities in the Gulf.
.

Valentin Corejl

Valentin Corelj performs data analysis to help develop advanced medical profiling systems.

Valentin graduated in Biochemistry from the University of Belgrade having specialised in immunochemistry.

He spent two years as a freelance academic writer and data analyst before joining Augmented Health (sister company to Optimised Healthcare) in 2015.

Valentin has specialist interests in the clinical biochemistry aspects of personalised medicine and in developing advanced biomedical data analysis systems.

Nenad Strainovic

As backend developer and IT manager, Nenad Strainovic brings over 18 years expertise to Optimise Healthcare’s team and is excited about working at the cutting edge of developing software applications.

Nenad has held positions including Technical Director, System Administrator and PHP & MySQL Developer for numerous companies including RUF Television in Serbia, before becoming director of FastNet International Ltd, an award-winning Business Internet Service Provider. He was one of the co-founders of Burek, one of the most successful forums in Serbia with more that two-million members.

Milos Jeremic

Making digital products is Milos’ job and passion. From information architecture, through design and development to the launch of final, and he’s been doing it for over 9 years.

He worked at Frame as a Lead UI/UX Designer and Front-end developer, where he helped shape the future of app streaming.

Prior to that he worked as a freelance designer, front-end developer and a consultant providing service to both small and large organisations.

At Optimised Healthcare, Milos heads up user interface and user experience design aw well as front-end development, and is looking forward to making an impact on the future of healthcare management.

Dr Jelena Dragicevic

Dr Jelena Dragicevic has particular interests in neurobiology and the functional anatomy of emotions.

She has previously held roles at the Petnica Science Centre and the University of Belgrade as well as having spent time at the SaMED 1st International Medical Students Congress in Sarajevo and also the IFMSA exchange at the Department of Biomedical Metabolic and Neural Sciences in Italy.

Dr Dragicevic won the award for ‘best student in generation’ at both elementary and high school. Since 2014, she has volunteered at the Brain Awareness Week in Belgrade and in 2015 took a role on the organisations board.

Dr Charlotte Lawson

Dr Charlotte Lawson is a senior lecturer in Comparative Biomedical Sciences at the Royal Veterinary College. She is also a member of the Cardiovascular and Inflammation biology research group. Her main research interests are leukocyte-endothelial cell interactions, microparticle production and adhesion molecule signalling.

After graduating from Wye College (University of London) with BSc in Animal Science, Dr Lawson undertook an ARC funded research studentship at the Kennedy Institute of Rheumatology, supervised by Professor Yuti Chemajovsky and Professor Marc Feldmann, and was awarded a PhD in 1997. From 1998 to 2003 she took up a BHF funded post-doctoral position at Imperial College (Harefield Hospital) with Marlene Rose in the transplant immunology group.

In 2001, she was awarded a three-year BHF Intermediate Fellowship to pursue independent research. Dr Lawson moved to the Royal Veterinary College in 2004 as a lecturer and member of the Cardiovascular and Inflammation biology research group. She is interested in all aspects of vascular inflammation. Her current research focuses on leukocyte-endothelial cell interactions under static and hemodynamic conditions (including microparticle production, adhesion molecule signalling, autoantibody-mediated cell activation and leukocyte activation mediated by uptake of dietary fats).

Dr Kerry McLaughlin

Dr Kerry McLaughlin is a JDRF Research Fellow at the Oxford Centre for Diabetes, Endocrinology & Metabolism at the University of Oxford and specialises in Diabetology and Clinical Immunology.

Dr McLaughlin acquired her PhD in Immunology from King’s College London and a first-class honours BSc from the University of the West of England.

From 2009 to 2015, she held a Postdoctoral position in the Division of Diabetes and Nutritional Sciences at King’s College London. In 2012, Dr McLaughlin won an Early Career Grant from the Society for Endocrinology and in 2006, secured the Pfzer Prize for Innovation from the BBSRC Biotechnology Young Entrepreneurs Scheme. She holds a published patent and was selected to join the Diabetes UK ‘Innovators in Diabetes’ programme in 2017.

A prolific science writer and editor, she has had numerous papers published in the field of Diabetes as well as verification and translation of journals from foreign sources.

As one of the youngest members of the Optimise Scientific Advisory Board, Dr McLaughlin is keen to explore the next generation of technology usage trends alongside her interests in the prediction of disease and autoimmunity.

Dr Sharmila Bakshi

Dr Sharmila Bakshi is an experienced biotechnology specialist with a PhD in Molecular Microbiology from the University of Oxford.

In addition to her PhD, Dr Bakshi has an MSc in Molecular Genetics and BSc (Hons) in Biochemistry from the Universities of Oxford, Leicester and Kent at Canterbury respectively. She also has a Graduate Diploma in Law from Bpp Law School, London.

A drug development expert, she has extensive experience in advising pharmaceutical companies on vaccines, adjuvants, anti-infectives, biologics, therapeutics, medical devices and diagnostics. She has worked with Intercell (now Valneva), Sanofi Pasteur and the European Vaccine Initiative.

Dr Bakshi is familiar with the priorities of academic, industry, non-profit and governmental research organisations. She is experienced in leading the lifecycle management of critical research and development projects as well as establishing and maintaining successful collaborations between academia and industry.

A forward-thinking entrepreneur, Dr Bakshi established Personalize My Medicine to deliver research and condition-specific information to patients online and to provide medical innovations directly to individuals.

Dr Sharon Brookes

Dr Sharon Brookes is the Head of Avian Virology and Mammalian Influenza at APHA-Weybridge and a Research Scientist for the Civil Service – a position she has held for 16 years.

Australian-born Dr Brookes acquired a PhD in Virology from La Trobe University in Melbourne. She has held postdoctoral positions at the Kennedy Institute for Rheumatology in Oxford and The Pirbright Institute in Surrey, attaining UK citizenship after 27 years of work and study.

Dr Brookes spent more that seven years working for AHVLA, first as Mammalian Influenza Team Leader, then as Influenza Research Leader and Acting Head on Avian Virology and Mammalian Influenza. She also specialises in electron microscopy and BTV morphogenesis.

She is a prolific writer of research publications, book chapters and trade press on the subject of Virology and Immunology. Dr Brookes has also achieved awards from the Microbiology Society. Her primary interest is in zoonotic biology and vaccine intervention and she is proud to have become leader of the influenza research team, acting as disease consultant for the British Government.

Dr Claire Morgan

Dr Claire Morgan has more than 25 years’ experience in the scientific field. She has a PhD from the University of London in Immunology and Biochemistry and a BSc (Hons) in Applied Biological Sciences from the University of West England.

From 1996 to 1999 she worked as a Post-Doctoral Research Scientist at the Anthony Nolan Bone Marrow Trust at the Royal Free Hospital, London, and from 1999 to 2001 spent time as a Clinical Scientist in the Immunopathology Department at St Bartholomew’s Hospital, London.

More recently Claire was Head of Business Development at Ludger Ltd, a bioscience company specialising in analytical technology for medical applications of glycobiology. She developed a particular expertise in the commercialisation of new technologies for glycosylation analysis and became proficient in understanding specific client requirements with regards to glycoprofiling services and products including biosimilar and innovator characterisation.

Claire is currently with the University of Oxford where she manages a new shared laboratory initiative, the Agile Lab, for the University.

Andrew Mark

Andrew Mark is a highly-regarded sales and marketing professional with over 30 years experience and expertise in the medical diagnostic and life-science research sectors.

Andrew studied Applied Biology at university, specialising in Biochemistry, Pharmacology and Microbiology. He spent some time during his studies at the Microbiology Research Establishment (now Health Protection Agency). Andrew is a Global Expert Manager for Abingdon Health, having previously held roles at EuroSciCon, the Cell Therapy Catapult, Beckman Coulter, Serono Diagnostics and Pharmacia Diagnostics. His experience in these roles and ongoing interests encompasses cellular analysis, genetic analysis, allergy diagnostics, clinical flow cytometry and haematological malignancy.

He has considerable experience in leading and influencing external organisations and with communicating complex technology and concepts to a broad audience.

Niga Nawroly

Niga Nawroly is a Medical Research Scientist and Immunologist with a broad experience in Flow Cytometry. She is currently a FLow Cytometry Specialist at ACEA Biosciences.

Niga holds an MSc in Immunology from Imperial College London and a BSc in Biology from Salahaddin University-Erbil. She has worked on various research projects for the Royal Postgraduate Medical School, The Kennedy Institute of Rheumatology, Queen Mary University of London and Imperial College London. Her studies include Immunology of transplantation & xeno-transplantation, diabetes mellitus, autoimmune diseases, virology and respiratory medicine.

Prior to her current role, Niga worked as European Flow Cytometry Specialist at Bio-Rad Laboratories and Business Development Manager/Application Scientist at eBioscience. She is the eFounder of biotechnology company Flowise Scientific Ltd, and for more than ten years was Head of Flow Cytometry at Imperial College London.

Niga’s proudest achievement is establishing a business teaching facility at Imperial College London, which has been running off over eleven years and brings important fundraising to the institution. She is the author of a number of peer-reviewed scientific papers and developed an important study into the genetic aspect of diabetes in relation to identical twins.

Niga is currently the Outreach Committee Member and Flow Cytometry Section Committee Member at the Royal Microscopical Society. She is an expert coach and mentor and brings a wealth of sales and commercialisation knowledge to the Advisory Board.

Ralph Coney

Ralph Coney is Chief Operating Officer at BJS Biotechnologies Ltd with specialist skills in molecular biology, biotechnology and medical devices.

Ralph is a highly-regarded professional who has spent more that seven years as MD at Novusci Ltd and held the Sales and Marketing Director position at BJS Biotechnologies.

Graduating from the University of Hertfordshire with honours in Applied Biology, Ralph combines his knowledge of medical science with key skills in sales and marketing management, general management, managing and driving change and growth.

As an inspirational commercial leader, he is used to fast-changing working environments and short deadlines. A consistent high-performer, Ralph is driven by transforming and growing businesses.

Trevor Fitzpatrick

With over 30 years experience in the field of medical science, Trevor Fitzpatrick brings a wealth of knowledge of clinical research trials and commercialisation to the Scientific Advisory Board.

Trevor gained a BSc (Hons) in Applied Biology and is a Certified Medical Publication Professional (CMAPP). He has since been associated with first-in-class launches in several disease categories. His particular interests lie in Cardiovascular medicine and Psychiatry. He has been extensively involved with pharmaceutical product development, data analytics and dissemination procedures for numerous high-profile drug providers.

Trevor is the author of several published works and is an experienced speaker at multiple industry events. He has been on the adjudication panel for the UK Pharmaceutical Industry Marketing Awards and is excited about developing next generation medicine with Optimise.

Personalised

Deliver truly personalised care and advice to your clients or patients, based on their own individual genetics and health parameters. From tailored advice on supplements and nutrition, to complex fitness strategies, disease prediction, monitoring and management, the benefits of real personalisation are available in all settings.